EFFICACY OF OMEGA-3 POLYUNSATURATED FATTY ACID FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES: CURRENT STATE OF THE PROBLEM
In this review, the advisability of broad prophylactic and therapeutic application of ω-3 polyunsaturated fatty acids (ω-3 PUFA) in various cardiovascular diseases (CVD) is proved. Epidemiological studies show a positive effect of ω-3 PUFAs on the risk of CVD complications. Results of numerous clinical studies evaluating the efficacy of ω-3 PUFA for the primary and secondary prevention of coronary heart disease after coronary artery stenting, heart rhythm disturbances, heart failure, and dyslipidemia are discussed. A number of studies confirm the benefits of drugs containing ω-3 PUFAs, with respect to both the degree of frequency and clinical efficacy in comparison with their other sources.